Literature DB >> 20933619

Parental origin and functional relevance of a de novo UBE3A variant.

Bernhard Horsthemke1, Michaela Wawrzik, Stephanie Gross, Christina Lich, Birgitta Sauer, Imma Rost, Ernst Krasemann, Nadezda Kosyakova, Thomas Liehr, Anja Weise, J Nikolaj Dybowski, Daniel Hoffmann, Dagmar Wieczorek.   

Abstract

Sequence analysis of the imprinted UBE3A gene in a 3-year-old girl suspected of having Angelman syndrome had revealed a de novo 3bp in frame deletion predicted to encode a protein lacking the amino acid G538 (based on sequence NM_130838). In order to assess the clinical relevance of this unknown variant, we determined the parental origin and the functional consequences of the deletion. We separated the two chromosomes 15 by microdissection of metaphase spreads and used cytogenetic and molecular markers to demonstrate that the deletion is on the maternal chromosome. For determining the functional consequences of the deletion, we modelled the structure of the deletion mutant based on the wildtype X-ray structure and simulated the molecular dynamics of the wildtype and mutant protein in complex with UcbH7. Our simulations showed that deletion of G538 destroys a network of salt bridges between highly conserved residues in the catalytic cleft of UBE3A. In conclusion, our results strongly suggest that the 3bp deletion is a loss-of-function mutation of the maternal UBE3A allele that has caused Angelman syndrome in our patient. Our study may serve as a paradigm to determine the parental origin of a de novo mutation.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20933619     DOI: 10.1016/j.ejmg.2010.09.005

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  6 in total

1.  E6-Associated Protein Dependent Estrogen Receptor Regulation of Protein Kinase A Regulatory Subunit R2A Expression in Neuroblastoma.

Authors:  Jean-Pierre Obeid; Youssef H Zeidan; Nawal Zafar; Jimmy El Hokayem
Journal:  Mol Neurobiol       Date:  2017-02-18       Impact factor: 5.590

2.  Molecular and Clinical Aspects of Angelman Syndrome.

Authors:  A Dagli; K Buiting; C A Williams
Journal:  Mol Syndromol       Date:  2011-07-28

3.  Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations.

Authors:  Stijn N V Bossuyt; A Mattijs Punt; Ilona J de Graaf; Janny van den Burg; Mark G Williams; Helen Heussler; Ype Elgersma; Ben Distel
Journal:  Hum Mol Genet       Date:  2021-04-30       Impact factor: 6.150

4.  Angelman syndrome-derived neurons display late onset of paternal UBE3A silencing.

Authors:  Jana Stanurova; Anika Neureiter; Michaela Hiber; Hannah de Oliveira Kessler; Kristin Stolp; Roman Goetzke; Diana Klein; Agnes Bankfalvi; Hannes Klump; Laura Steenpass
Journal:  Sci Rep       Date:  2016-08-03       Impact factor: 4.379

5.  Imprinted Gene Expression and Function of the Dopa Decarboxylase Gene in the Developing Heart.

Authors:  Adam R Prickett; Bertille Montibus; Nikolaos Barkas; Samuele M Amante; Maurício M Franco; Michael Cowley; William Puszyk; Matthew F Shannon; Melita D Irving; Marta Madon-Simon; Andrew Ward; Reiner Schulz; H Scott Baldwin; Rebecca J Oakey
Journal:  Front Cell Dev Biol       Date:  2021-06-22

6.  Chromosomes in a genome-wise order: evidence for metaphase architecture.

Authors:  Anja Weise; Samarth Bhatt; Katja Piaszinski; Nadezda Kosyakova; Xiaobo Fan; Annelore Altendorf-Hofmann; Alongklod Tanomtong; Arunrat Chaveerach; Marcelo Bello de Cioffi; Edivaldo de Oliveira; Joachim-U Walther; Thomas Liehr; Jyoti P Chaudhuri
Journal:  Mol Cytogenet       Date:  2016-04-27       Impact factor: 2.009

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.